Printed Circuit Boards (“PCB”s) are ushering in a new era in healthcare, driving breakthroughs in both traditional and emerging medical devices. From AI-powered diagnostic platforms and remote patient monitoring systems to next-generation wearables, PCBs are critical in the latest innovations. According to the latest market analysis, the global medical PCB sector is expected to reach $3.2 billion by 2026, with a robust CAGR of 7.8% since 2023—underscoring the growing demand for reliable, high-performance medical electronics.
As medical devices become more sophisticated, PCB design and manufacturing standards have risen sharply. Today’s medical-grade PCBs feature high-density interconnects, flexible and rigid-flex designs, and biocompatible materials to meet the needs of compact and wearable technologies. Compliance with certifications such as ISO 13485 is now essential, reflecting the sector’s commitment to safety, reliability, and full lifecycle traceability for all PCB components.
At TTM, our specialized factories position us to support our customers by addressing a broad spectrum of medical industry requirements with PCB products, substrates, specialty components, value-add assemblies, and other highly engineered custom solutions. TTM is committed to advancing medical technology and supporting the community. Read further to learn about our new president and CEO announcement, our Q2, 2025 results, and our latest corporate social responsibility accomplishments.
